Dominique Maraninchi


Ontology type: schema:Person     


Person Info

NAME

Dominique

SURNAME

Maraninchi

Publications in SciGraph latest 50 shown

  • 2011-07-04 Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs in BONE MARROW TRANSPLANTATION
  • 2010-06-29 Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2006-06-12 A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma in BONE MARROW TRANSPLANTATION
  • 2005-09-26 Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy in ONCOGENE
  • 2005-09-05 Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2005-06-17 Postoperative serum proteomic profiles and identification of biomarkers with prognosis value in high-risk early breast cancer patients in BREAST CANCER RESEARCH
  • 2004-11-15 Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling in ONCOGENE
  • 2004-05-10 Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2004-03-08 Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment in BONE MARROW TRANSPLANTATION
  • 2004-03 Les banques de tissus tumoraux appliquées au cancer du sein : pourquoi? Comment? in ONCOLOGIE
  • 2004-03 Les mesures de la qualité de vie en cancérologie peuvent-elles hanger la pratique des cliniciens? in ONCOLOGIE
  • 2004-02 Traitement précoce de l’anémie, en cours de chimiothérapie, par érythropoïétine : qu’attendre d’un schéma simplifié? À propos de l’expérience de l’Institut Paoli Calmettes-Marseille in ONCOLOGIE
  • 2003-11-24 Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution in BONE MARROW TRANSPLANTATION
  • 2003-11-18 Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy in BONE MARROW TRANSPLANTATION
  • 2003-08-14 Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen in LEUKEMIA
  • 2003-05-15 Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation in LEUKEMIA
  • 2003-04-08 Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation in LEUKEMIA
  • 2003 Feasibility of High Dose Melphalan (140 mg/m2) and Peripheral Blood Stem Cell Support as Consolidation for Patients over 60 Years with Acute Myeloid Leukemia in First Complete Remission in ACUTE LEUKEMIAS IX
  • 2002-12-12 Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study in BONE MARROW TRANSPLANTATION
  • 2002-10-02 Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis in LEUKEMIA
  • 2002-10 Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2002-06-21 Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens in BONE MARROW TRANSPLANTATION
  • 2002-05-23 Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2002-04 Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles in SUPPORTIVE CARE IN CANCER
  • 2001-12 Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report in BONE MARROW TRANSPLANTATION
  • 2000-09 Autologous peripheral blood stem cell transplantation (PBSCT) in acute myeloid leukaemia (AML) in first complete remission (CR) a report of the BGMT cooperative group about 32 patients in ANNALS OF HEMATOLOGY
  • 2000-07-28 High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation in BONE MARROW TRANSPLANTATION
  • 2000-07-07 High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results in BONE MARROW TRANSPLANTATION
  • 2000-01-25 Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center in BONE MARROW TRANSPLANTATION
  • 1999-07-23 Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD in BONE MARROW TRANSPLANTATION
  • 1999-06-12 Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high–intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin’s lymphoma: an oligocentric report on 42 patients in LEUKEMIA
  • 1999-04 Association of angiogenesis and poor prognosis in node‐positive patients receiving anthracycline‐based adjuvant chemotherapy in BREAST CANCER RESEARCH AND TREATMENT
  • 1999-04 The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell® technology in ANNALS OF HEMATOLOGY
  • 1999-02 Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involment in ANNALS OF HEMATOLOGY
  • 1998-12-17 Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study in BONE MARROW TRANSPLANTATION
  • 1998-10 High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study in BRITISH JOURNAL OF CANCER
  • 1998-02 High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome in BONE MARROW TRANSPLANTATION
  • 1998 High Dose, Low Dose, No Dose: The Rights and Wrongs of Medical Oncology in THE ROLE OF MULTIPLE INTENSIFICATION IN MEDICAL ONCOLOGY
  • 1998 Intensive Sequential Chemotherapy for Untreated Poor-Risk Non-Hodgkin’s Lymphoma in THE ROLE OF MULTIPLE INTENSIFICATION IN MEDICAL ONCOLOGY
  • 1998 Phase I–II Study of Carboplatin with VP16 and Aracytin for Poor-Risk-Acute Leukemia in ACUTE LEUKEMIAS VII
  • 1997-12 Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care in BRITISH JOURNAL OF CANCER
  • 1997-08 High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer in BONE MARROW TRANSPLANTATION
  • 1997-06 Early and fatal immune haemolysis after so-called ‘minor’ ABO-incompatible peripheral blood stem cell allotransplantation in BONE MARROW TRANSPLANTATION
  • 1997-05 Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia in BONE MARROW TRANSPLANTATION
  • 1997-05 Detection of CBFβ/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics in LEUKEMIA
  • 1997-05 Autologous Peripheral Blood Progenitor-Cell Transplantation versus Autologous Bone Marrow Transplantation for Adults and Children with Non-Leukaemic Malignant Disease in PHARMACOECONOMICS
  • 1996 IL2 in Acute Leukemia in ACUTE LEUKEMIAS V
  • 1994 Phase I-II trial of Seraspenide (AcSDKP): a supressor of myelopoiesis protects against chemotherapy myelotoxicity (version 10 february 1993) in CANCER TREATMENT AN UPDATE
  • 1993-06 Autoimmune polyendocrine failure — Type 1 (insulin-dependent) diabetes mellitus and hypothyroidism — after allogenic bone marrow transplantation in a patient with lymphoblastic leukaemia in DIABETOLOGIA
  • 1993 Bone Marrow Transplantation for Chronic Myeloid Leukemia in France. Results of the French Cooperative Group in LEUKEMIAS
  • Affiliations

  • Centre de Recherche en Cancérologie de Marseille (current)
  • Ludwig Cancer Research
  • Nottingham City Hospital
  • Hôpital René Huguenin
  • Délégation Régionale Provence-Alpes-Côte d’Azur et Corse
  • Sanofi (France)
  • Leicester Royal Infirmary
  • Roche (Switzerland)
  • Cliniques Universitaires Saint-Luc
  • Hôpital Saint-Antoine
  • Ludwig Cancer Research
  • University of Lausanne
  • Institut Claudius Regaud
  • Danaher (France)
  • University of Perugia
  • Hôpital Saint-Louis
  • Policlinico di Modena
  • Centre Léon Bérard
  • Royal Melbourne Hospital
  • Institut Bergonié
  • Centre Hospitalier Universitaire d'Angers
  • Ministère des Solidarités et de la Santé
  • Centre d’Immunologie de Marseille-Luminy
  • Hôpital Purpan
  • Cancéropôle PACA
  • Hôpital de la Timone
  • Centre Jean Perrin
  • Hospital Universitario Miguel Servet
  • Istituti Fisioterapici Ospitalieri
  • Hôpital Édouard-Herriot
  • UniCancer Group
  • University of Strasbourg
  • Centre Eugène Marquis
  • Hôpital Lapeyronie
  • Leiden University Medical Center
  • Johannes Gutenberg University of Mainz
  • Institute Curie
  • St. James's Hospital
  • Aix-Marseille University
  • St Vincent's Hospital
  • Assistance Publique – Hôpitaux de Paris
  • University Hospital of Geneva
  • Centre Hospitalier Universitaire de Nîmes
  • Pitié-Salpêtrière Hospital
  • University Hospital of Montpellier
  • Inserm
  • Centre Hospitalier Universitaire de Bordeaux
  • Institut Gustave Roussy
  • Centre Hospitalier Universitaire de Besançon
  • Roche (United Kingdom)
  • Hospital Clínico Universitario de Valencia
  • Institute Paoli-Calmettes
  • University of Franche-Comté
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.463833.9", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.486806.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412920.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418205.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.457381.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417924.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419248.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417570.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.48769.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412370.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1052.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9851.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417829.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.424937.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9027.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413328.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413363.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418116.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416153.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476460.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411147.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418199.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417850.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414282.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.469376.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411266.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418113.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411106.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417520.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412180.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418189.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.11843.3f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417988.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411572.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10419.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5802.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418596.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416409.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5399.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413105.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.50550.35", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.150338.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411165.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411439.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.157868.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7429.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.42399.35", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411158.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419227.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411308.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418443.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7459.f", 
            "type": "Organization"
          }
        ], 
        "familyName": "Maraninchi", 
        "givenName": "Dominique", 
        "id": "sg:person.01364057057.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364057057.31"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2021-12-01T20:42", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/person/person_762.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01364057057.31'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01364057057.31'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01364057057.31'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01364057057.31'


     

    This table displays all metadata directly associated to this object as RDF triples.

    120 TRIPLES      10 PREDICATES      63 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01364057057.31 schema:affiliation Nf6996e6fe3254ecb8d9fb648539bed83
    2 grid-institutes:grid.10419.3d
    3 grid-institutes:grid.1052.6
    4 grid-institutes:grid.11843.3f
    5 grid-institutes:grid.14925.3b
    6 grid-institutes:grid.150338.c
    7 grid-institutes:grid.157868.5
    8 grid-institutes:grid.411106.3
    9 grid-institutes:grid.411147.6
    10 grid-institutes:grid.411158.8
    11 grid-institutes:grid.411165.6
    12 grid-institutes:grid.411266.6
    13 grid-institutes:grid.411308.f
    14 grid-institutes:grid.411439.a
    15 grid-institutes:grid.411572.4
    16 grid-institutes:grid.412180.e
    17 grid-institutes:grid.412370.3
    18 grid-institutes:grid.412920.c
    19 grid-institutes:grid.413105.2
    20 grid-institutes:grid.413328.f
    21 grid-institutes:grid.413363.0
    22 grid-institutes:grid.414282.9
    23 grid-institutes:grid.416153.4
    24 grid-institutes:grid.416409.e
    25 grid-institutes:grid.417520.5
    26 grid-institutes:grid.417570.0
    27 grid-institutes:grid.417829.1
    28 grid-institutes:grid.417850.f
    29 grid-institutes:grid.417924.d
    30 grid-institutes:grid.417988.b
    31 grid-institutes:grid.418113.e
    32 grid-institutes:grid.418116.b
    33 grid-institutes:grid.418189.d
    34 grid-institutes:grid.418199.c
    35 grid-institutes:grid.418205.a
    36 grid-institutes:grid.418443.e
    37 grid-institutes:grid.418596.7
    38 grid-institutes:grid.419227.b
    39 grid-institutes:grid.419248.2
    40 grid-institutes:grid.42399.35
    41 grid-institutes:grid.424937.f
    42 grid-institutes:grid.457381.c
    43 grid-institutes:grid.469376.9
    44 grid-institutes:grid.476460.7
    45 grid-institutes:grid.486806.4
    46 grid-institutes:grid.48769.34
    47 grid-institutes:grid.50550.35
    48 grid-institutes:grid.5399.6
    49 grid-institutes:grid.5802.f
    50 grid-institutes:grid.7429.8
    51 grid-institutes:grid.7459.f
    52 grid-institutes:grid.9027.c
    53 grid-institutes:grid.9851.5
    54 schema:familyName Maraninchi
    55 schema:givenName Dominique
    56 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364057057.31
    57 schema:sdDatePublished 2021-12-01T20:42
    58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    59 schema:sdPublisher N03b4149c58454c5e917a68b3a2871b4f
    60 sgo:license sg:explorer/license/
    61 sgo:sdDataset persons
    62 rdf:type schema:Person
    63 N03b4149c58454c5e917a68b3a2871b4f schema:name Springer Nature - SN SciGraph project
    64 rdf:type schema:Organization
    65 Nf6996e6fe3254ecb8d9fb648539bed83 schema:affiliation grid-institutes:grid.463833.9
    66 sgo:isCurrent true
    67 rdf:type schema:OrganizationRole
    68 grid-institutes:grid.10419.3d schema:Organization
    69 grid-institutes:grid.1052.6 schema:Organization
    70 grid-institutes:grid.11843.3f schema:Organization
    71 grid-institutes:grid.14925.3b schema:Organization
    72 grid-institutes:grid.150338.c schema:Organization
    73 grid-institutes:grid.157868.5 schema:Organization
    74 grid-institutes:grid.411106.3 schema:Organization
    75 grid-institutes:grid.411147.6 schema:Organization
    76 grid-institutes:grid.411158.8 schema:Organization
    77 grid-institutes:grid.411165.6 schema:Organization
    78 grid-institutes:grid.411266.6 schema:Organization
    79 grid-institutes:grid.411308.f schema:Organization
    80 grid-institutes:grid.411439.a schema:Organization
    81 grid-institutes:grid.411572.4 schema:Organization
    82 grid-institutes:grid.412180.e schema:Organization
    83 grid-institutes:grid.412370.3 schema:Organization
    84 grid-institutes:grid.412920.c schema:Organization
    85 grid-institutes:grid.413105.2 schema:Organization
    86 grid-institutes:grid.413328.f schema:Organization
    87 grid-institutes:grid.413363.0 schema:Organization
    88 grid-institutes:grid.414282.9 schema:Organization
    89 grid-institutes:grid.416153.4 schema:Organization
    90 grid-institutes:grid.416409.e schema:Organization
    91 grid-institutes:grid.417520.5 schema:Organization
    92 grid-institutes:grid.417570.0 schema:Organization
    93 grid-institutes:grid.417829.1 schema:Organization
    94 grid-institutes:grid.417850.f schema:Organization
    95 grid-institutes:grid.417924.d schema:Organization
    96 grid-institutes:grid.417988.b schema:Organization
    97 grid-institutes:grid.418113.e schema:Organization
    98 grid-institutes:grid.418116.b schema:Organization
    99 grid-institutes:grid.418189.d schema:Organization
    100 grid-institutes:grid.418199.c schema:Organization
    101 grid-institutes:grid.418205.a schema:Organization
    102 grid-institutes:grid.418443.e schema:Organization
    103 grid-institutes:grid.418596.7 schema:Organization
    104 grid-institutes:grid.419227.b schema:Organization
    105 grid-institutes:grid.419248.2 schema:Organization
    106 grid-institutes:grid.42399.35 schema:Organization
    107 grid-institutes:grid.424937.f schema:Organization
    108 grid-institutes:grid.457381.c schema:Organization
    109 grid-institutes:grid.463833.9 schema:Organization
    110 grid-institutes:grid.469376.9 schema:Organization
    111 grid-institutes:grid.476460.7 schema:Organization
    112 grid-institutes:grid.486806.4 schema:Organization
    113 grid-institutes:grid.48769.34 schema:Organization
    114 grid-institutes:grid.50550.35 schema:Organization
    115 grid-institutes:grid.5399.6 schema:Organization
    116 grid-institutes:grid.5802.f schema:Organization
    117 grid-institutes:grid.7429.8 schema:Organization
    118 grid-institutes:grid.7459.f schema:Organization
    119 grid-institutes:grid.9027.c schema:Organization
    120 grid-institutes:grid.9851.5 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...